Archive for March, 2011

Study warns of birth defects risk for painkillers during pregnancy

According to new data from the Centers for Disease Control and Prevention, women who use opioid painkillers during pregnancy or up to one month before they become pregnant are twice as likely to give birth to a child with heart defects or other birth defects. The study was published in the American Journal of Obstetrics and Gynecology.

Click here to read more…

Pain medications linked to increased birth defects risk

A study published by the American Journal of Obstetrics and Gynecology has found that women who use Vicodin, codeine, oxycodone, OxyContin or other pain medications at the start of pregnancy are twice as likely to give birth to a child with certain types of serious birth defects.

Click here to read more…

Evidence of Avandia side effects risk grows after new study

A new study published by the British Medical Journal has found that patients taking Avandia are more likely to suffer congestive heart failure, heart attack and other side effects compared to other diabetes drugs. Avandia was recalled by the European Medicines Agency over safety concerns in September 2010, although it is still available for sale in the U.S.

Click here to read more…

The Catch-22 of Antidepressants

The catch-22 of antidepressant therapy is the depression that comes from gaining weight on a drug used to stop the depression. Many are halting their use of these drugs because they cannot stand to live in a body blown up by the overeating generated by the medications.

Click here to read more…

Zoloft linked to increased birth defects risk

Women who use the antidepressant drug Zoloft during pregnancy are more likely to give birth to children with serious and potentially fatal heart defects or other congenital birth defects. The Food and Drug Administration has warned that the use of Zoloft while pregnant—especially during the third trimester—could cause harm to the fetus through congenital birth defects.

Click here to read more…

 

FDA issues Topamax warning over new birth defects data

The Food and Drug Administration has warned that women who use the migraine and epilepsy drug Topamax while pregnant may be more likely to give birth to a child with a cleft lip, cleft palate or other birth defects. Based on new data about the risk of Topamax birth defects, the FDA upgraded the drug to Pregnancy Category D, meaning that the drug has a proven risk of birth defects.

Click here to read more…

FDA issues warning about Topamax birth defects risk

The Food and Drug Administration has issued a warning about the epilepsy and migraine drug Topamax due to its increased risk of causing birth defects. The FDA’s Topamax warning came after recently released data showed that women taking the drug while pregnant were three times more likely to give birth to a child with cleft lips or cleft palate deformities than women taking similar medications.

Click here to read more…


Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 434 other followers

Contact Us:

Hissey Kientz, LLP

9442 Capital of Texas Hwy N.

Arboretum Plaza One, Suite 400

Austin, Texas 78759

Toll-free: (866) 275-4454

Facsimile: (512) 320-9101

Email: info@hkllp.com

Sponsored By:

Hissey Kientz, LLP (Austin, TX)

Attorney Michael Hissey is responsible for the content of this website.